US$ 28.61
bpc 157 clinical trial human dosing bpc-157 protocol BPC-157 Dosing (Common Protocols) πΉ Oral / Subcutaneous β’ 500 mcg daily β’ Duration: 6 weeks πΉ Intramuscular / Peritendinous β’ 1 mg daily β’ Duration: 6 weeks β οΈ Note: Not approved BPC-157 for Shoulder Injuries: Dosing
Description
Apart from low doses, when opting for protocols with weekly macrodoses of supplementation or booster doses, we must provide a very high intake of B12 to ensure that we cover the absorption of a small but sufficient fraction, even at the expense of the vast majority of the B12 in the supplement not being utilized and being eliminated due to the lower absorption efficiency found with this route, as it is not dependent on the intrinsic factor

M.HenryL
Let's walk through it together

Hach, M., Engelund, D
How Peptides Work Peptides act at the cellular level, stimulating various biological processes